The relation between glycemic control and HDL-C in type 2 diabetes: a preliminary step forward?

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Low high-density lipoprotein cholesterol (HDL-C) is a risk factor for cardiovascular (CV) disease, particularly in type 2 diabetes (T2D).
• Current therapies aimed at increasing HDL-C have not proven effective in reducing CV risk.
• The relationship between glycemic control and HDL-C levels in T2D requires further investigation.

Purpose of the Study:

• To evaluate the impact of improved glycemic control on HDL-C levels in patients with type 2 diabetes.
• To explore potential correlations between glycemic control improvements and HDL-C changes, especially in subgroups with low baseline HDL-C.

Main Methods:

• A 6-month intervention study was conducted.
• Participants with type 2 diabetes underwent interventions aimed at improving glycemic control.
• Changes in HbA1c and HDL-C levels were measured before and after the intervention.

Main Results:

• The intervention led to a significant improvement in HbA1c levels.
• Overall, HDL-C levels did not show a significant improvement.
• In a subgroup analysis, patients with initially low HDL-C levels demonstrated a significant inverse relationship between improved HbA1c and HDL-C levels.

Conclusions:

• Intensified glycemic control may positively influence HDL-C levels in type 2 diabetes patients with low baseline HDL-C.
• Further research is warranted to explore the therapeutic potential of glycemic control for modulating HDL-C and reducing cardiovascular risk in T2D.
• The findings suggest a potential benefit of optimizing blood glucose management for lipid profiles in specific T2D populations.